Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Pharming (Euronext:PHARM) gained EUR 0.61 (27%) to EUR 2.83 on Tuesday after reporting
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury